Oral Fosfomycin versus Ciprofloxacin for Febrile Urinary Tract Infection in Men: a pilot study
- Conditions
- Febrile urinary tract infection in men
- Registration Number
- NL-OMON25027
- Lead Sponsor
- Haga Teaching Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Competent male patient aged 18 years or above
2.One or more symptom(s) suggestive of urinary tract infection (dysuria, frequency or urgency*; perineal or suprapubic pain; costo-vertebral tenderness or flank pain)
Exclusion Criteria
1.Known allergy to fosfomycin or ciprofloxacin
2.Patients with known polycystic kidney disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is the clinical cure rate 10-18 days post-treatment.
- Secondary Outcome Measures
Name Time Method Test of Cure (10-18 days post-treatment):<br /><br>bacteriologic cure rate<br /><br>all-cause mortality<br /><br>adverse events<br /><br>Late follow up (70- to 84 days post-treatment):<br /><br>clinical cure rate<br /><br>all-cause mortality<br /><br>relapse rate of UTI<br>